Ken Fisher’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,674
Closed -$275K 1197
2023
Q1
$275K Sell
11,674
-4,228
-27% -$114K ﹤0.01% 932
2022
Q4
$444K Sell
15,902
-2,697
-15% -$69K ﹤0.01% 850
2022
Q3
$435K Buy
18,599
+1,383
+8% +$41.8K ﹤0.01% 768
2022
Q2
$581K Buy
17,216
+231
+1% +$8.09K ﹤0.01% 694
2022
Q1
$593K Sell
16,985
-3,583
-17% -$123K ﹤0.01% 703
2021
Q4
$626K Sell
20,568
-3,193
-13% -$104K ﹤0.01% 719
2021
Q3
$779K Sell
23,761
-943,699
-98% -$30.2M ﹤0.01% 658
2021
Q2
$29.3M Buy
+967,460
New +$31.8M 0.02% 282

Other funds holding OGN

Ken Fisher's OGN Position: Q2 2023 in Review

Ken Fisher sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 11,674 shares — an estimated $275K sold.

Ken Fisher first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $29.3M in Q2 2021. 728 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Ken Fisher reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Ken Fisher sold 11,674 Organon & Co shares in Q2 2023, an estimated $275K.
  • Ken Fisher first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Ken Fisher's Organon & Co position peaked at $29.3M in Q2 2021.
  • 728 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Fisher Asset Management's 13F filing for Q2 2023, filed 8 Aug 2023.